These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18845489)

  • 1. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update.
    Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H
    Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1315-41; quiz 1286. PubMed ID: 18845489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
    Martin P; Lau DT; Nguyen MH; Janssen HL; Dieterich DT; Peters MG; Jacobson IM
    Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2071-87.e16. PubMed ID: 26188135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update.
    Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H; Wright TL
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):936-62. PubMed ID: 16844425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States.
    Keeffe EB; Dieterich DT; Han SH; Jacobson IM; Martin P; Schiff ER; Tobias H; Wright TL
    Clin Gastroenterol Hepatol; 2004 Feb; 2(2):87-106. PubMed ID: 15017613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: current antiviral therapy of chronic hepatitis B.
    Ayoub WS; Keeffe EB
    Aliment Pharmacol Ther; 2008 Jul; 28(2):167-77. PubMed ID: 18466358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance.
    Sun J; Hou JL; Xie Q; Li XH; Zhang JM; Wang YM; Wang H; Lai JY; Chen SJ; Jia JD; Sheng JF; Chan HL; Wang JF; Li MK; Jiang M; Popescu M; Sung JJ
    Aliment Pharmacol Ther; 2011 Aug; 34(4):424-31. PubMed ID: 21692822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peginterferon for the treatment of chronic hepatitis B in the era of nucleos(t)ide analogues.
    Buster EH; Schalm SW; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1093-108. PubMed ID: 19187869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal therapy of chronic hepatitis B: how do I treat my HBeAg-negative patients?
    Viganò M; Invernizzi F; Lampertico P
    Liver Int; 2015 Jan; 35 Suppl 1():107-13. PubMed ID: 25529095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues.
    Jansen L; Kootstra NA; van Dort KA; Takkenberg RB; Reesink HW; Zaaijer HL
    J Infect Dis; 2016 Jan; 213(2):224-32. PubMed ID: 26216905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended treatment with peginterferon α-2a in combination with lamivudine or adefovir for 96 weeks yields high rates of HBeAg and HBsAg seroconversion.
    Cao ZH; Ma LN; Zhang HW; Liu YL; Chen XY
    J Dig Dis; 2013 Aug; 14(8):446-50. PubMed ID: 23615131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
    Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
    J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early serum hepatitis B virus large surface protein level: a stronger predictor of virological response to peginterferon alfa-2a than that to entecavir in HBeAg-positive patients with chronic hepatitis B.
    Zhu X; Gong Q; Yu D; Zhang D; Gu L; Han Y; Chen J; Zhang Y; Zhang X
    J Clin Virol; 2013 Aug; 57(4):318-22. PubMed ID: 23639294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy.
    Park JG; Park SY
    Clin Mol Hepatol; 2015 Sep; 21(3):242-8. PubMed ID: 26523269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and emerging treatment of chronic hepatitis B.
    Keeffe EB; Marcellin P
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):285-94. PubMed ID: 17218162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B infection: an update of Swedish recommendations.
    Lindh M; Uhnoo I; Bläckberg J; Duberg AS; Friman S; Fischler B; Karlström O; Norkrans G; Reichard O; Sangfeldt P; Söderström A; Sönnerborg A; Weiland O; Wejstål R; Wiström J
    Scand J Infect Dis; 2008; 40(6-7):436-50. PubMed ID: 18584530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir rescue regimen following prior suboptimal response to entecavir and adefovir combination therapy in chronic hepatitis B patients exposed to multiple treatment failures.
    Zhang Q; Han T; Nie CY; Ha FS; Liu L; Liu H
    J Med Virol; 2015 Jun; 87(6):1013-21. PubMed ID: 25716029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir and entecavir are the most effective antiviral agents for chronic hepatitis B: a systematic review and Bayesian meta-analyses.
    Woo G; Tomlinson G; Nishikawa Y; Kowgier M; Sherman M; Wong DK; Pham B; Ungar WJ; Einarson TR; Heathcote EJ; Krahn M
    Gastroenterology; 2010 Oct; 139(4):1218-29. PubMed ID: 20600036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
    Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?
    Buster EH; Janssen HL
    Neth J Med; 2006 Jun; 64(6):175-85. PubMed ID: 16788215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.